Results 191 to 200 of about 44,865 (239)

East meets West: The winning combination against <i>BRAF V600E</i> metastatic colorectal cancer. [PDF]

World J Clin Oncol
Liu WM, Li XB.
europepmc   +1 more source

A plain language summary of the molecular changes in the tumors of people with BRAF V600E-mutant colorectal cancer in the BEACON study. [PDF]

Future Oncol
Kopetz S, Murphy DA, Pu J, Ciardiello F, Desai J, Van Cutsem E, Wasan HS, Yoshino T, Saffari H, Zhang X, Hamilton P, Xie T, Yaeger R, Tabernero J.   +13 more
europepmc   +1 more source

Response to dabrafenib and trametinib combined with pembrolizumab in an elderly patient with lung adenocarcinoma of unknown primary harboring BRAF V600E mutation and high PD-L1 expression: a case report. [PDF]

Front Immunol
Li N, Hu J, Bao G, Cai Z.
europepmc   +1 more source

Using liquid biopsies to guide treatment and monitor response in BRAF V600E positive adenocarcinoma of unknown primary. [PDF]

BMJ Case Rep
Papayanis PN, Au C, Jelinek M, Tan A.
europepmc   +1 more source

Rare Case of Severe Pancreatitis Induced by Encorafenib and Cetuximab in BRAF V600E-Positive Colorectal Cancer. [PDF]

Intern Med
Miyakawa Y, Ishigaki Y, Suzuki N, Endo G, Suzumori C, Hayashi T, Tamada K, Iwata T, Fujisawa G, Hayakawa Y, Boku N, Fujishiro M.   +11 more
europepmc   +1 more source

GLİOBLASTOMLARDA BRAF V600E MUTASYON VE BRAF VE1 İMMUNEKSPRESYON PROFİLİ

, 2017
TOSUNER, ZEYNEP, GEÇER, MELİN, HATİBOĞLU, MUSTAFA AZİZ, ABDALLAH, ANAS, TURNA, SEVAL   +4 more
openaire   +1 more source

BRAF V600E-mutated lung adenocarcinoma with thyroid metastasis as the initial manifestation: a case report. [PDF]

Front Oncol
Liu Y, Lei H, Cai L, Tan Y, Song X.
europepmc   +1 more source

OT17 a novel microsatellite stable colorectal cancer cell line and organoid model for investigating <i>BRAF V600E</i> mutant tumorigenesis and targeted therapeutics. [PDF]

Biochem Biophys Rep
Zheng C, Tang X, Wang S, Xu Y, Jia K, Gao G, Wei G, Niu G, Wu Y, Qian X, Zhu Y, Xiang D.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

BRAF V600E-mutierte Gliome

Onkologische Welt, 2021
Neue Daten, die auf der Jahrestagung der American Association for Cancer Research 2021 (AACR) präsentiert wurden, bestätigen die Kombination von Dabrafenib (Tafinlar®) und Trametinib (Mekinist®) als mögliche Therapieoption bei Patienten mit hoch- und niedriggradigen Hirntumoren mit einer BRAF V600E-Mutation.
openaire   +1 more source